Variant report
Variant | nsv544212 |
---|---|
Chromosome Location | chr20:22233715-22256861 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:52)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FOXA2-13 | chr20:22252690-22254092 | NONHSAT078968 |
2 | lnc-FOXA2-8 | chr20:22255046-22255149 | NONHSAT078967 |
3 | lnc-FOXA2-8 | chr20:22255046-22255184 | XLOC_013679 |
4 | lnc-FOXA2-8 | chr20:22243347-22243872 | NONHSAT078967 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000225170 | TF binding region |
UBE2F | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs145204431 | chr20:22240811-22240812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs116359453 | chr20:22240871-22240872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs6082658 | chr20:22240893-22240894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs373146737 | chr20:22240911-22240912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs531438230 | chr20:22240976-22240977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs536414314 | chr20:22240980-22240981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548331248 | chr20:22240990-22240991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562063967 | chr20:22241005-22241006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs140849583 | chr20:22241014-22241015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537734509 | chr20:22241022-22241023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs7265696 | chr20:22241043-22241044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs181722296 | chr20:22241081-22241082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs804687 | chr20:22241100-22241101 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs6047980 | chr20:22241137-22241138 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs570345851 | chr20:22241157-22241158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs138675323 | chr20:22241182-22241183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs574459651 | chr20:22241196-22241197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs571550504 | chr20:22241225-22241226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533929747 | chr20:22241238-22241239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs539065225 | chr20:22241239-22241240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs560818955 | chr20:22241254-22241255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs577923689 | chr20:22241313-22241314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs140502898 | chr20:22241370-22241371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs17814988 | chr20:22241403-22241404 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs73899961 | chr20:22241424-22241425 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs572177313 | chr20:22241434-22241435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs1337908 | chr20:22241466-22241467 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs145643709 | chr20:22241509-22241510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs541661727 | chr20:22241557-22241558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs138270715 | chr20:22241558-22241559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs7266078 | chr20:22241600-22241601 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs376922657 | chr20:22241712-22241713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs547915349 | chr20:22241732-22241733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs78944212 | chr20:22241811-22241812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs533398391 | chr20:22241813-22241814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs550162853 | chr20:22241893-22241894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs554725698 | chr20:22241904-22241905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs570381718 | chr20:22241936-22241937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs529711031 | chr20:22241980-22241981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs576601876 | chr20:22242005-22242006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs370432581 | chr20:22242006-22242007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs536109309 | chr20:22242012-22242013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs549404804 | chr20:22242025-22242026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs566312147 | chr20:22242028-22242029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs543755505 | chr20:22242057-22242058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs142876871 | chr20:22242078-22242079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs565610638 | chr20:22242124-22242125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs553487008 | chr20:22242148-22242149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs144320459 | chr20:22242215-22242216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs148344990 | chr20:22242222-22242223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Alagille syndrome | 17576883 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16608533 | CNVD |
Cancer | 20164919 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:22240800-22241600 | Enhancers | Fetal Stomach | stomach |
2 | chr20:22241000-22242000 | Enhancers | Dnd41 | blood |
3 | chr20:22241000-22242200 | Enhancers | Colon Smooth Muscle | Colon |
4 | chr20:22241000-22242200 | Enhancers | Fetal Lung | lung |
5 | chr20:22241000-22242600 | Enhancers | Rectal Smooth Muscle | rectum |
6 | chr20:22241200-22241400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
7 | chr20:22241200-22241800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr20:22242600-22251200 | Weak transcription | Rectal Smooth Muscle | rectum |
9 | chr20:22248600-22249600 | Enhancers | Dnd41 | blood |
10 | chr20:22251000-22252400 | Enhancers | Stomach Smooth Muscle | stomach |
11 | chr20:22251000-22252600 | Enhancers | Fetal Stomach | stomach |
12 | chr20:22251200-22251800 | Enhancers | Colon Smooth Muscle | Colon |
13 | chr20:22251200-22251800 | Enhancers | Rectal Smooth Muscle | rectum |
14 | chr20:22254800-22255200 | Enhancers | HSMMtube | muscle |
15 | chr20:22256200-22257000 | Enhancers | Dnd41 | blood |